Elena Massarotti

6.7k total citations
31 papers, 1.3k citations indexed

About

Elena Massarotti is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Elena Massarotti has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 12 papers in Immunology and 7 papers in Genetics. Recurrent topics in Elena Massarotti's work include Systemic Lupus Erythematosus Research (16 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Elena Massarotti is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Elena Massarotti collaborates with scholars based in United States, Italy and Canada. Elena Massarotti's co-authors include Bing Lü, Daniel H. Solomon, Rajesh Garg, Karen H. Costenbader, Ann Mullally, Nancy Berliner, Annemarie E. Fogerty, Alison M. Schram, Donna Neuberg and Federico Campigotto and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Elena Massarotti

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Massarotti United States 18 697 532 241 152 152 31 1.3k
Andrea Becciolini Italy 19 743 1.1× 386 0.7× 276 1.1× 167 1.1× 99 0.7× 57 1.3k
Martina Biggioggero Italy 23 1.1k 1.5× 555 1.0× 362 1.5× 181 1.2× 152 1.0× 69 1.7k
Marcel D. Posthumus Netherlands 20 671 1.0× 347 0.7× 215 0.9× 285 1.9× 78 0.5× 30 1.4k
Luis H. Silveira United States 20 762 1.1× 329 0.6× 137 0.6× 187 1.2× 116 0.8× 48 1.4k
Hideko Nakahara Japan 10 481 0.7× 330 0.6× 286 1.2× 227 1.5× 117 0.8× 20 1.2k
Jerzy Świerkot Poland 22 795 1.1× 438 0.8× 320 1.3× 254 1.7× 55 0.4× 99 1.5k
Wenhui Xie China 22 533 0.8× 317 0.6× 127 0.5× 215 1.4× 115 0.8× 93 1.4k
Prabha Ranganathan United States 20 692 1.0× 214 0.4× 271 1.1× 143 0.9× 69 0.5× 53 1.3k
Bridget Hodkinson South Africa 18 727 1.0× 218 0.4× 228 0.9× 177 1.2× 45 0.3× 48 1.1k
Agnes L. Maier United States 14 636 0.9× 283 0.5× 366 1.5× 124 0.8× 55 0.4× 22 1.1k

Countries citing papers authored by Elena Massarotti

Since Specialization
Citations

This map shows the geographic impact of Elena Massarotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Massarotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Massarotti more than expected).

Fields of papers citing papers by Elena Massarotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Massarotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Massarotti. The network helps show where Elena Massarotti may publish in the future.

Co-authorship network of co-authors of Elena Massarotti

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Massarotti. A scholar is included among the top collaborators of Elena Massarotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Massarotti. Elena Massarotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zureigat, Hadil, Shady Abohashem, Michael T. Osborne, et al.. (2024). Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritis. Journal of Nuclear Cardiology. 33. 101813–101813. 1 indexed citations
2.
Jonsson, A. Helena, Fan Zhang, Garrett S. Dunlap, et al.. (2022). Granzyme K + CD8 T cells form a core population in inflamed human tissue. Science Translational Medicine. 14(649). eabo0686–eabo0686. 131 indexed citations
3.
Weber, Brittany, Emma Stevens, Camden Bay, et al.. (2021). Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus. Journal of the American Heart Association. 10(13). e018555–e018555. 32 indexed citations
4.
Nabel, Christopher S., Mariano Severgnini, Yin P. Hung, et al.. (2019). Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer. The Oncologist. 24(8). 1013–1021. 11 indexed citations
5.
Wohlfahrt, Alyssa, Maura D. Iversen, Joshua J. Gagne, et al.. (2018). Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings. PLoS ONE. 13(7). e0200886–e0200886. 10 indexed citations
6.
Massarotti, Elena, et al.. (2014). Development of SLE among “potential SLE” patients seen in consultation: long-term follow-up. International Journal of Clinical Practice. 68(12). 1508–1513. 30 indexed citations
7.
Merola, Joseph F., Bonnie L. Bermas, Bing Lü, et al.. (2014). Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus. 23(8). 778–784. 50 indexed citations
8.
9.
Schram, Alison M., Ann Mullally, Annemarie E. Fogerty, Elena Massarotti, & Nancy Berliner. (2014). Hemophagocytic Lymphohistiocytosis: The Partners Healthcare Experience over the Past 8 Years. Blood. 124(21). 4104–4104. 2 indexed citations
10.
Merola, Joseph F., Stephen D. Prystowsky, José A. Gómez‐Puerta, et al.. (2013). Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. Journal of the American Academy of Dermatology. 69(1). 19–24. 24 indexed citations
11.
12.
Girouard, Sasha D., Nicole F. Vélez, Richard T. Penson, Elena Massarotti, & Ruth Ann Vleugels. (2012). Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer. Archives of Dermatology. 148(6). 740–4. 12 indexed citations
13.
Garg, Rajesh, et al.. (2012). Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals. Arthritis Research & Therapy. 14(3). R135–R135. 74 indexed citations
14.
Massarotti, Elena & Peter H. Schur. (2011). To What Extent Can Preventive Treatments Prevent Damage From Systemic Lupus Erythematosus?. Current Rheumatology Reports. 13(4). 317–323. 3 indexed citations
15.
Costenbader, Karen H., Amrita Desai, Graciela S. Alarcón, et al.. (2011). Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis & Rheumatism. 63(6). 1681–1688. 179 indexed citations
16.
Massarotti, Elena. (2009). FAST4WARD: implications for the clinician. International Journal of Clinical Practice. 63(7). 986–988. 1 indexed citations
17.
Ollendorf, Daniel A., Elena Massarotti, C. Birbara, & Somali M. Burgess. (2005). Frequency, Predictors, and Economic Impact of Upward Dose Adjustment of Infliximab in Managed Care Patients With Rheumatoid Arthritis. Journal of Managed Care Pharmacy. 11(5). 383–393. 32 indexed citations
18.
Massarotti, Elena, et al.. (2005). Rheumatoid Arthritis: An Overview of New and Emerging Therapies. The Journal of Clinical Pharmacology. 45(7). 751–762. 134 indexed citations
19.
Fischer, Peter, Alex Kopp, & Elena Massarotti. (1996). Anaerobic Septic Bursitis: Case Report and Review. Clinical Infectious Diseases. 22(5). 879–879. 4 indexed citations
20.
Massarotti, Elena, et al.. (1992). Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy. The American Journal of Medicine. 92(6). 693–697. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Becciolini Breakdown of academic impact, for papers by Martina Biggioggero Breakdown of academic impact, for papers by Marcel D. Posthumus Breakdown of academic impact, for papers by Luis H. Silveira Breakdown of academic impact, for papers by Hideko Nakahara Breakdown of academic impact, for papers by Jerzy Świerkot Breakdown of academic impact, for papers by Wenhui Xie Breakdown of academic impact, for papers by Prabha Ranganathan Breakdown of academic impact, for papers by Bridget Hodkinson Breakdown of academic impact, for papers by Agnes L. Maier
Rankless by CCL
2026